{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:00:51Z","timestamp":1790114451630,"version":"4.0.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,22]]},"DOI":"10.1093\/cid\/ciad248","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T22:35:58Z","timestamp":1682548558000},"page":"583-588","source":"Crossref","is-referenced-by-count":7,"title":["Intralesional Antimonial Drug Treatment for <i>Leishmania braziliensis<\/i> Cutaneous Leishmaniasis: The Knowns and the Unknowns"],"prefix":"10.1093","volume":"77","author":[{"given":"Naomi E","family":"Aronson","sequence":"first","affiliation":[{"name":"Infectious Diseases Division, Uniformed Services University of the Health Sciences , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Billick","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"2023082219382990200_ciad248-B1","volume-title":"Guideline for the treatment of leishmaniasis in the Americas","author":"Pan American Health Organization","year":"2022","edition":"2nd ed."},{"key":"2023082219382990200_ciad248-B2","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2023082219382990200_ciad248-B3","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jaad.2016.01.042","article-title":"Creating a guard with a needle cover to control the depth of intralesional injections","volume":"75","author":"Gupta","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2023082219382990200_ciad248-B4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.soc.2014.12.007","article-title":"Intralesional therapy for in-transit and satellite metastases in melanoma","volume":"24","author":"Feeney","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"2023082219382990200_ciad248-B5","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1245\/s10434-014-4169-5","article-title":"Phase 2 study of intralesional PV-10 in refractory metastatic melanoma","volume":"22","author":"Thompson","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2023082219382990200_ciad248-B6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/107327481602300104","article-title":"Developments in intralesional therapy for metastatic melanoma","volume":"23","author":"Sloot","year":"2016","journal-title":"Cancer Control"},{"key":"2023082219382990200_ciad248-B7","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14386","article-title":"Intralesional immunotherapy for molluscum contagiosum: a review","volume":"33","author":"Wells","year":"2020","journal-title":"Dermatol Ther"},{"key":"2023082219382990200_ciad248-B8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40257-013-0018-8","article-title":"Intralesional antigen immunotherapy for the treatment of warts: current concepts and future prospects","volume":"14","author":"Nofal","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"2023082219382990200_ciad248-B9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/pde.14094","article-title":"Intralesional immunotherapy for pediatric warts: a review","volume":"37","author":"Fields","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"2023082219382990200_ciad248-B10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/0074-027601700125","article-title":"Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment","volume":"113","author":"Silva","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2023082219382990200_ciad248-B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaad.2005.05.044","article-title":"Surgical pearl: a novel technique to contain the backspray from intralesional injections","volume":"54","author":"Freed","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2023082219382990200_ciad248-B12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0035-9203(93)90093-6","article-title":"Antimonial treatment of hamsters infected with Leishmania (Viannia) panamensis: assessment of parasitological cure with different therapeutic schedules","volume":"87","author":"Travi","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/AAC.39.2.516","article-title":"Skin uptake, distribution, and elimination of antimony following administration of sodium stibogluconate to patients with cutaneous leishmaniasis","volume":"39","author":"al Jaser","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2023082219382990200_ciad248-B14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/tmi.13130","article-title":"Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate","volume":"23","author":"de Aguiar","year":"2018","journal-title":"Trop Med Int Health"},{"key":"2023082219382990200_ciad248-B15","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1365-3156.2009.02408.x","article-title":"Antimony in plasma and skin of patients with cutaneous leishmaniasis\u2014relationship with side effects after treatment with meglumine antimoniate","volume":"14","author":"Neves","year":"2009","journal-title":"Trop Med Int Health"},{"key":"2023082219382990200_ciad248-B16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/clinchem\/36.4.680","article-title":"Retention of antimony in skin biopsies of leishmaniasis patients after treatment with N-methylglucamine antimoniate","volume":"36","author":"Dorea","year":"1990","journal-title":"Clin Chem"},{"key":"2023082219382990200_ciad248-B17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1179\/136485906X78472","article-title":"Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites","volume":"100","author":"Najim","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"2023082219382990200_ciad248-B18","first-page":"238","article-title":"Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy","volume":"14","author":"Shamsi Meymandi","year":"2011","journal-title":"Arch Iran Med"},{"key":"2023082219382990200_ciad248-B19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004178","article-title":"The immunology of a healing response in cutaneous leishmaniasis treated with localized heat or systemic antimonial therapy","volume":"9","author":"Lakhal-Naouar","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2023082219382990200_ciad248-B20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.trstmh.2005.08.011","article-title":"Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy","volume":"100","author":"Lobo","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B21","first-page":"219","article-title":"[Pluri-focal cutaneous leishmaniasis treated with intralesional glucantime]","volume":"73","author":"Duperrat","year":"1966","journal-title":"Bull Soc Fr Dermatol Syphil"},{"key":"2023082219382990200_ciad248-B22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4269\/ajtmh.14-0787","article-title":"Lymphatic dissemination in cutaneous leishmaniasis following local treatment","volume":"93","author":"Thomaidou","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.trstmh.2012.03.007","article-title":"A proposed new clinical staging system for patients with mucosal leishmaniasis","volume":"106","author":"Lessa","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.4269\/ajtmh.21-0928","article-title":"Treatment of Bolivian Leishmania braziliensis cutaneous and mucosal leishmaniasis","volume":"106","author":"Soto","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010931","article-title":"The cure rate after different treatments for mucosal leishmaniasis in the Americas: a systematic review","volume":"16","author":"Carvalho","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2023082219382990200_ciad248-B26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"Blum","year":"2012","journal-title":"Int Health"},{"key":"2023082219382990200_ciad248-B27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1590\/S0102-311X2000000400013","article-title":"The epidemiology and control of leishmaniasis in Andean countries","volume":"16","author":"Davies","year":"2000","journal-title":"Cad Saude Publica"},{"key":"2023082219382990200_ciad248-B28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0035-9203(86)90243-9","article-title":"Mucosal leishmaniasis (\u201cespundia\u201d Escomel, 1911)","volume":"80","author":"Marsden","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B29","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz055","article-title":"Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis","volume":"26","author":"Boggild","year":"2019","journal-title":"J Travel Med"},{"key":"2023082219382990200_ciad248-B30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3201\/eid2504.180239","article-title":"Mucosal leishmaniasis in travelers with Leishmania braziliensis complex returning to Israel","volume":"25","author":"Solomon","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2023082219382990200_ciad248-B31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/0037-8682-0052-2015","article-title":"Detection of Leishmania (Viannia) DNA in leucocytes from the blood of patients with cutaneous leishmaniasis","volume":"48","author":"Conter","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"key":"2023082219382990200_ciad248-B32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/600109","article-title":"Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species","volume":"200","author":"Figueroa","year":"2009","journal-title":"J Infect Dis"},{"key":"2023082219382990200_ciad248-B33","doi-asserted-by":"crossref","first-page":"e1816","DOI":"10.1371\/journal.pntd.0001816","article-title":"Transcriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans","volume":"6","author":"Maretti-Mira","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2023082219382990200_ciad248-B34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149697","article-title":"The cure rate after placebo or no therapy in American cutaneous leishmaniasis: a systematic review and meta-analysis","volume":"11","author":"Cota","year":"2016","journal-title":"PLoS One"},{"key":"2023082219382990200_ciad248-B35","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"Pinart","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2023082219382990200_ciad248-B36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/cit049","article-title":"Intralesional antimony for single lesions of Bolivian cutaneous leishmaniasis","volume":"56","author":"Soto","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2023082219382990200_ciad248-B37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4269\/ajtmh.15-0640","article-title":"Intralesional pentamidine: a novel therapy for single lesions of Bolivian cutaneous leishmaniasis","volume":"94","author":"Soto","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184777","article-title":"Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: a systematic review","volume":"12","author":"Brito","year":"2017","journal-title":"PLoS One"},{"key":"2023082219382990200_ciad248-B39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/tropicalmed7100286","article-title":"Intralesional meglumine antimoniate: safe, feasible and effective therapy for cutaneous leishmaniasis in Bolivia","volume":"7","author":"Rojas Cabrera","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"2023082219382990200_ciad248-B40","doi-asserted-by":"crossref","first-page":"e0009734","DOI":"10.1371\/journal.pntd.0009734","article-title":"An old drug and different ways to treat cutaneous leishmaniasis: intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil","volume":"15","author":"Oliveira-Ribeiro","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2023082219382990200_ciad248-B41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijpddr.2020.11.002","article-title":"A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis","volume":"14","author":"Rodrigues","year":"2020","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2023082219382990200_ciad248-B42","article-title":"Is the intralesional treatment of cutaneous leishmaniasis safe against the risk of mucosal complications?","volume-title":"Gaceta M\u00e9dica Boliviana","author":"Limachi-Choque","year":"2020"},{"key":"2023082219382990200_ciad248-B43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.actatropica.2019.03.007","article-title":"Comparison between systemic and intralesional meglumine antimoniate therapy in a primary health care unit","volume":"193","author":"de Oliveira Duque","year":"2019","journal-title":"Acta Trop"},{"key":"2023082219382990200_ciad248-B44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.actatropica.2018.06.001","article-title":"Successful treatment against American cutaneous leishmaniasis by intralesional infiltration of a generic antimonial compound-lidocaine combination. A follow up study","volume":"185","author":"Anez","year":"2018","journal-title":"Acta Trop"},{"key":"2023082219382990200_ciad248-B45","doi-asserted-by":"crossref","first-page":"e180200","DOI":"10.1590\/0074-02760180200","article-title":"Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial","volume":"113","author":"Ramalho","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2023082219382990200_ciad248-B46","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4269\/ajtmh.17-0340","article-title":"Intralesional infiltration with meglumine antimoniate for the treatment of leishmaniasis recidiva cutis in Ecuador","volume":"97","author":"Calvopina","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B47","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1590\/0074-02760160478","article-title":"Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001\u20132013)","volume":"112","author":"Brahim","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2023082219382990200_ciad248-B48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1590\/0074-02760160183","article-title":"Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre","volume":"111","author":"Silva","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2023082219382990200_ciad248-B49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4269\/ajtmh.2012.11-0612","article-title":"Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006)","volume":"87","author":"Ede","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"2023082219382990200_ciad248-B50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-4362.1997.00188.x","article-title":"Mattos M, da Costa SC, Pirmez C. Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil\u2014an area of Leishmania (V.) braziliensis transmission","volume":"36","author":"Oliveira-Neto","year":"1997","journal-title":"Int J Dermatol"},{"key":"2023082219382990200_ciad248-B51","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1590\/0037-8682-0213-2016","article-title":"Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis","volume":"49","author":"Duque","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"2023082219382990200_ciad248-B52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"2023082219382990200_ciad248-B53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14787210.2020.1731305","article-title":"Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis","volume":"18","author":"Fernandes","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2023082219382990200_ciad248-B54","volume-title":"Ending the neglect to attain the sustainable development goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases","author":"World Health Organization","year":"2022"},{"key":"2023082219382990200_ciad248-B55","doi-asserted-by":"crossref","first-page":"e0007856","DOI":"10.1371\/journal.pntd.0007856","article-title":"Intralesional infiltration vs parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: a cost-effectiveness analysis","volume":"13","author":"Brito","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2023082219382990200_ciad248-B56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29333\/jcei\/11516","article-title":"Leishmania recidivans could be induced by intralesional infiltration of cutaneous leishmaniasis by sodium stibogluconate, with new therapeutic trial","volume":"13","author":"Sharquie","year":"2022","journal-title":"J Clin Exp Invest"},{"key":"2023082219382990200_ciad248-B57"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad248\/50449007\/ciad248.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/4\/583\/51224136\/ciad248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/4\/583\/51224136\/ciad248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T19:40:38Z","timestamp":1692733238000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/4\/583\/7143571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,26]]},"published-print":{"date-parts":[[2023,8,22]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad248","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,15]]},"published":{"date-parts":[[2023,4,26]]}}}